Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320717156> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4320717156 endingPage "109263" @default.
- W4320717156 startingPage "109263" @default.
- W4320717156 abstract "Immunosuppressives (IS) are the choice of treatment for major organ involvement in Behçet's disease (BD). In this study, we aimed to investigate the relapse rate and new major organ development in BD under ISs during long-term follow-up.The files of 1114 BD patients followed in Marmara University Behçet's Clinic were analyzed retrospectively. Patients with a follow-up less than 6 months were excluded. Conventional IS and biologic treatment courses were compared. 'Events under IS' were defined as a relapse of the same organ and/or new major organ development in patients receiving ISs.Among 806 patients included in the final analysis (male: 56%, age at diagnosis: 29 (23-35) years, median follow-up time: 68 (33-106) months). Major organ involvement was present in 232 (50.5%) patients at diagnosis, and 227 (49.5%) developed new major organ involvement during follow-up. Major organ involvement developed earlier in males (p = 0.012) and in patients with a first-degree relative history of BD (p = 0.066). ISs were given mostly for major organ involvement (86.8%, n = 440). Overall, 36% of the patients had a relapse or new major organ involvement under ISs (relapse: 30.9%, new major organ involvement: 11.6%.) 'Events under IS' (35.5% vs 20.8%, p = 0.004), and relapses (29.3% vs 13.9%, p = 0.001) were more common with conventional ISs compared to biologics.Any major event under ISs was less common with biologics compared to conventional ISs in patients with BD. These results suggest that earlier and more aggressive treatment may be an option in BD patients who had the highest risk for severe disease course." @default.
- W4320717156 created "2023-02-15" @default.
- W4320717156 creator A5017846081 @default.
- W4320717156 creator A5019220311 @default.
- W4320717156 creator A5029797000 @default.
- W4320717156 creator A5033453458 @default.
- W4320717156 creator A5059784966 @default.
- W4320717156 creator A5061617645 @default.
- W4320717156 creator A5090437449 @default.
- W4320717156 date "2023-03-01" @default.
- W4320717156 modified "2023-10-18" @default.
- W4320717156 title "Earlier and more aggressive treatment with biologics may prevent relapses and further new organ involvement in Behçet's disease" @default.
- W4320717156 cites W1991528145 @default.
- W4320717156 cites W1992539694 @default.
- W4320717156 cites W2000471297 @default.
- W4320717156 cites W2006150593 @default.
- W4320717156 cites W2010722948 @default.
- W4320717156 cites W2022237635 @default.
- W4320717156 cites W2049056531 @default.
- W4320717156 cites W2052564277 @default.
- W4320717156 cites W2053503514 @default.
- W4320717156 cites W2063323018 @default.
- W4320717156 cites W2102997845 @default.
- W4320717156 cites W2123263694 @default.
- W4320717156 cites W2135761968 @default.
- W4320717156 cites W2151429640 @default.
- W4320717156 cites W2157065994 @default.
- W4320717156 cites W2519862651 @default.
- W4320717156 cites W2800472118 @default.
- W4320717156 cites W2887666249 @default.
- W4320717156 cites W2895504592 @default.
- W4320717156 cites W2913306648 @default.
- W4320717156 cites W2930587512 @default.
- W4320717156 cites W2944549872 @default.
- W4320717156 cites W2972846107 @default.
- W4320717156 cites W3037905620 @default.
- W4320717156 cites W3161625089 @default.
- W4320717156 cites W4200153051 @default.
- W4320717156 cites W998070158 @default.
- W4320717156 cites W2006735413 @default.
- W4320717156 doi "https://doi.org/10.1016/j.clim.2023.109263" @default.
- W4320717156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36796468" @default.
- W4320717156 hasPublicationYear "2023" @default.
- W4320717156 type Work @default.
- W4320717156 citedByCount "4" @default.
- W4320717156 countsByYear W43207171562023 @default.
- W4320717156 crossrefType "journal-article" @default.
- W4320717156 hasAuthorship W4320717156A5017846081 @default.
- W4320717156 hasAuthorship W4320717156A5019220311 @default.
- W4320717156 hasAuthorship W4320717156A5029797000 @default.
- W4320717156 hasAuthorship W4320717156A5033453458 @default.
- W4320717156 hasAuthorship W4320717156A5059784966 @default.
- W4320717156 hasAuthorship W4320717156A5061617645 @default.
- W4320717156 hasAuthorship W4320717156A5090437449 @default.
- W4320717156 hasConcept C126322002 @default.
- W4320717156 hasConcept C141071460 @default.
- W4320717156 hasConcept C2779134260 @default.
- W4320717156 hasConcept C2781428731 @default.
- W4320717156 hasConcept C3018415437 @default.
- W4320717156 hasConcept C3018799218 @default.
- W4320717156 hasConcept C71924100 @default.
- W4320717156 hasConceptScore W4320717156C126322002 @default.
- W4320717156 hasConceptScore W4320717156C141071460 @default.
- W4320717156 hasConceptScore W4320717156C2779134260 @default.
- W4320717156 hasConceptScore W4320717156C2781428731 @default.
- W4320717156 hasConceptScore W4320717156C3018415437 @default.
- W4320717156 hasConceptScore W4320717156C3018799218 @default.
- W4320717156 hasConceptScore W4320717156C71924100 @default.
- W4320717156 hasLocation W43207171561 @default.
- W4320717156 hasLocation W43207171562 @default.
- W4320717156 hasOpenAccess W4320717156 @default.
- W4320717156 hasPrimaryLocation W43207171561 @default.
- W4320717156 hasRelatedWork W1978564353 @default.
- W4320717156 hasRelatedWork W2119148640 @default.
- W4320717156 hasRelatedWork W2159415366 @default.
- W4320717156 hasRelatedWork W2367662559 @default.
- W4320717156 hasRelatedWork W2392188314 @default.
- W4320717156 hasRelatedWork W2621341739 @default.
- W4320717156 hasRelatedWork W2891118528 @default.
- W4320717156 hasRelatedWork W3015484641 @default.
- W4320717156 hasRelatedWork W3083072852 @default.
- W4320717156 hasRelatedWork W4224990568 @default.
- W4320717156 hasVolume "248" @default.
- W4320717156 isParatext "false" @default.
- W4320717156 isRetracted "false" @default.
- W4320717156 workType "article" @default.